itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • What is the ideal length of a sales email? Insights based on 40 million emails

    28 июля, 2025

    Like most people, I don’t read all of the sales emails I get. When I do open an email, I skim its contents and immediately close out long, rambling messages, which is exactly why the search for the ideal email length is like Indiana Jones and the Holy Grail. It’s not about nitpicking word count;… →

    AI Sales
    AI, Analytics, B2BMarketing, B2BSales, BrandStrategy, ContentMarketing, ConversionOptimization, CustomerExperience, DataDriven, DigitalMarketing, Ecommerce, GrowthHacking, InboundMarketing, LeadGeneration, MarketingAutomation, MarketingTips, Salesforce, SEO, SocialSelling, TechnologyTrends
  • Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort

    28 июля, 2025

    CONCLUSIONS: Our study has identified several baseline metabolites and metabolic pathways associated with disease activity and response to different treatments in early RA. By integrating metabolomics and clinical data, we developed predictive models for response to treatment in early RA, though their predictive performance remains limited. →

    Clinical Trials
  • Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial

    28 июля, 2025

    CONCLUSION: Compared to MET monotherapy, combination therapy with semaglutide and MET significantly reduced body weight, improved insulin resistance, decreased inflammatory markers, alleviated and menstrual irregularities and increased natural pregnancy rates in overweight/obese women with PCOS. →

    Clinical Trials
  • Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA-related overgrowth spectrum or Proteus syndrome

    28 июля, 2025

    CONCLUSION: Miransertib was safe and tolerable in participants with a confirmed diagnosis of PROS or Proteus syndrome. Future investigations are needed to determine whether patients receive measurable clinical benefit from miransertib. →

    Clinical Trials
  • The VIP trial: a randomised controlled trial of the clinical effectiveness of a Victim Improvement Package (VIP) for the reduction of continued symptoms of depression or anxiety in older victims of community crime in an English city

    28 июля, 2025

    CONCLUSIONS: Community crime had long-lasting impacts. The police are ideally placed to screen for distress, present in 35% of victims, but only 58% of participants were recruited and the cognitive-behavioural therapy was not delivered competently. Further research on victim care and improving the delivery and quality of therapy is required. →

    Clinical Trials
  • The U.S. White House Releases AI Playbook: A Bold Strategy to Lead the Global AI Race

    27 июля, 2025

    «`html The U.S. White House Releases AI Playbook: A Bold Strategy to Lead the Global AI Race The White House has released the U.S. AI Playbook—formally titled “America’s AI Action Plan”—which outlines a comprehensive federal strategy emphasizing the United States’ commitment to artificial intelligence. This initiative aims to accelerate AI development across various sectors, from… →

    AI News
  • Building a Context-Aware Multi-Agent AI System Using Nomic Embeddings and Gemini LLM

    27 июля, 2025

    «`html Understanding the Target Audience The target audience for building a context-aware multi-agent AI system using Nomic embeddings and Gemini LLM primarily consists of: AI researchers and developers looking to implement advanced AI solutions. Business professionals interested in leveraging AI for improved decision-making and operational efficiency. Data scientists and machine learning engineers aiming to enhance… →

    AI News
  • VLM2Vec-V2: A Unified Computer Vision Framework for Multimodal Embedding Learning Across Images, Videos, and Visual Documents

    27 июля, 2025

    VLM2Vec-V2: A Unified Computer Vision Framework for Multimodal Embedding Learning Across Images, Videos, and Visual Documents Understanding the Target Audience The target audience for VLM2Vec-V2 primarily includes researchers, data scientists, and business professionals in the fields of artificial intelligence and computer vision. These individuals are typically engaged in developing or implementing AI solutions that require… →

    AI News
  • Key Factors That Drive Successful MCP Implementation and Adoption

    27 июля, 2025

    «`html Key Factors That Drive Successful MCP Implementation and Adoption The Model Context Protocol (MCP) is transforming the interaction between intelligent agents and backend services, applications, and data. A successful MCP implementation project requires more than just protocol-compliant code; it necessitates a systematic approach to adoption that encompasses architecture, security, user experience, and operational rigor.… →

    AI News
  • NVIDIA AI Dev Team Releases Llama Nemotron Super v1.5: Setting New Standards in Reasoning and Agentic AI

    27 июля, 2025

    «`html Understanding the Target Audience for Llama Nemotron Super v1.5 The target audience for NVIDIA’s Llama Nemotron Super v1.5 primarily includes AI developers, data scientists, and business leaders in technology-driven enterprises. These individuals are typically looking to enhance their AI capabilities for complex reasoning tasks and agentic applications. Pain Points Difficulty in achieving high accuracy… →

    AI News
Предыдущая страница
1 … 206 207 208 209 210 … 935
Следующая страница